ArticleInfectious disease reports2022

Treatment with Sotrovimab and Casirivimab/Imdevimab Enhances Serum SARS-CoV-2 S Antibody Levels in Patients Infected with the SARS-CoV-2 Delta, Omicron BA.1, and BA.5 Variants.

Kana Fujimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.